Interleukin 10
Interleukin 10 (IL-10) is an anti-inflammatory cytokine encoded by the IL10 gene.
Interleukin 10 (IL-10) is an anti-inflammatory cytokine encoded by the IL10 gene. It is produced by several immune-cell populations, including regulatory T cells, monocytes and macrophages, dendritic cells, and activated lymphocytes. IL-10 helps limit excessive immune activation and tissue injury by suppressing the production of proinflammatory cytokines such as Tumor necrosis factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β), and by reducing inflammatory antigen-presentation and macrophage activation.
IL-10 signals through the interleukin-10 receptor, a receptor complex that activates Janus kinase and STAT3-dependent transcription. Through this pathway, IL-10 can restrain inflammatory responses, neuroinflammation, and cytokine-driven tissue damage. Its activity is closely related to the balance between proinflammatory mediators, including interferon gamma, Interleukin-12 (IL-12), and Tumor necrosis factor-α (TNF-α), and regulatory pathways involving Interleukin-4 (IL-4), transforming growth factor-β (TGF-β), and regulatory T cell responses. IL-10 also intersects with processes involving oxidative stress, reactive oxygen species, apoptosis, and tissue repair. Because of these properties, IL-10 is studied as both a biomarker and a potential immunomodulatory target in injury, cancer, cardiovascular disease, and biomaterial-associated inflammation.
Where the papers sit
9 papers from the last 6 months study interleukin 10 directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 1 observational · 3 human data · 5 preclinical
Themes 3 themes
-
Localized Immune Modulation
Localized IL-10 delivery is moving toward cell- and organ-targeted immunomodulation rather than systemic cytokine exposure. Regulatory B cells and engineered cytokine-producing cells suppress myeloid-driven autoimmunity and foreign-body inflammation. Pancreas-directed lipid nanoparticles extend this strategy to IL-10 mRNA for acute pancreatitis. Durability, biodistribution, and translation from rodents to primates remain open.
3 papers · 33.3%
-
Phytochemical Mechanism Discovery
Network pharmacology and molecular docking are being used to connect phytochemicals with therapeutic targets in wound healing and hepatocellular carcinoma. Ginsenoside-Rd and compounds from Zanthoxylum nitidum are linked to pathways involving fibroblast proliferation, TNF signaling, and cancer-related regulation. Experimental verification is beginning to test computationally nominated mechanisms. Disease-specific efficacy and causal target validation remain limited.
2 papers · 22.2%
-
Others — Cytokine Immune Profiling
Cytokine measurements and immune-associated gene signatures are being used to characterize disease activity, tumor immunophenotype, and prognosis. IL-6, TNF-α, interferon gamma, CTLA-4, and related markers recur across neurological disease and cancer studies. Engineered IL-10-producing MSCs represent a therapeutic branch rather than a shared biomarker approach. The cluster lacks a unified clinical direction, linking immune assessment with exploratory intervention.
4 papers · 44.4%
Papers
The 9 papers from the last 6 months that study interleukin 10 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Localized Immune Modulation (3)
- Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity · 6 Oct 2026 PMID 42838057
- Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate. Science advances · 5 Aug 2026 PMID 42555743
- Pancreas-specific lipid nanoparticle-mediated interleukin-10 mRNA delivery ameliorates acute pancreatitis. Journal of materials chemistry. B · 3 Aug 2026 PMID 42544423
Phytochemical Mechanism Discovery (2)
- Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
- Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics. Artificial cells, nanomedicine, and biotechnology · 24 Jul 2026 PMID 42498300
Others — Cytokine Immune Profiling (4)
- Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human cell · 2 Sept 2026 PMID 42684559
- Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease. ACS applied bio materials · 10 Aug 2026 PMID 42575082
- Vasoactive intestinal peptide associated 8-gene signature with prognostic and immune associations in melanoma. Medicine · 30 May 2026 PMID 42216340
- Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension. Brain research · 29 May 2026 PMID 42214536
By study type
Observational studies and case reports (1)
- Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension. Brain research · 29 May 2026 PMID 42214536
Human data, design not indexed (3)
- Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human cell · 2 Sept 2026 PMID 42684559
- Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics. Artificial cells, nanomedicine, and biotechnology · 24 Jul 2026 PMID 42498300
- Vasoactive intestinal peptide associated 8-gene signature with prognostic and immune associations in melanoma. Medicine · 30 May 2026 PMID 42216340
Preclinical: animal, cell and lab studies (5)
- Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity · 6 Oct 2026 PMID 42838057
- Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
- Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease. ACS applied bio materials · 10 Aug 2026 PMID 42575082
- Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate. Science advances · 5 Aug 2026 PMID 42555743
- Pancreas-specific lipid nanoparticle-mediated interleukin-10 mRNA delivery ameliorates acute pancreatitis. Journal of materials chemistry. B · 3 Aug 2026 PMID 42544423
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-08-20. Drafted by language models from published abstracts; not medical advice.